MedPath

Intention Treatment for Anomia

Not Applicable
Active, not recruiting
Conditions
Stroke
Aphasia
Interventions
Behavioral: Intention Treatment for Anomia
Registration Number
NCT04267198
Lead Sponsor
VA Office of Research and Development
Brief Summary

Every year approximately 15,000 Veterans are hospitalized for stroke, and up to 40% of those Veterans will experience stroke-related language impairment (i.e., aphasia). Stroke-induced aphasia results in increased healthcare costs and decreased quality of life. As the population of Veterans continues to age, there will be an increasing number for Veterans living with the aphasia and its consequences. Those Veterans deserve to receive aphasia treatment designed to facilitate the best possible outcomes. In the proposed study, the investigators will investigate optimal treatment intensity and predictors of treatment response for a novel word retrieval treatment. The knowledge the investigators gain will have direct implications for the selecting the right treatment approach for the right Veteran.

Detailed Description

Difficulty retrieving words is one of the most common language complaints in individuals with stroke-induced aphasia. The negative consequences related to word retrieval impairment include increased health care costs and decreased quality of life. A variety of treatment approaches exist to improve word retrieval, and most of the treatments result in immediate improvement on trained words. However, long-term improvement and improvement on untrained words or behaviors is less common. Additionally, the investigators currently know very little about optimal treatment administration parameters, and the investigators know even less about predictors of treatment response. To make the best use of the limited clinical resources available for aphasia treatment, and to maximize outcomes for Veterans with aphasia, the investigators must: 1) develop clinically translatable treatments that yield widespread and lasting effects and 2) develop clinically accessible ways of identifying who will acquire benefit from a specific treatment approach. This study takes on these two challenges by investigating dose frequency (massed vs. distributed practice) effects and by identifying the language, cognitive and neural predictors of response to Intention treatment (INT), a novel word retrieval treatment. Specifically, the investigators will address the following aims:

Aim 1: To investigate dose frequency effects on maintenance and generalization of INT gains. Outcome measure: Word retrieval accuracy for trained and untrained words.

Aim 2: To identify the language and cognitive variables that predict response to m-INT vs. d-INT. Outcome measure: Language and cognitive ability as measured by standardized assessments.

Aim 3: To identify the neural predictors of response to m-INT vs. d-INT. Outcome measure: Tissue health and task activation location as measured by structural and functional MRI.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
32
Inclusion Criteria
  • English as primary language
  • > 6 months post-onset a left-hemisphere stroke. Multiple strokes are acceptable as long as they are confined to the left hemisphere.
  • Diagnosis of aphasia
  • Presence of word retrieval deficits
  • Adequate comprehension as judged by ability to complete two-step commands on the Western Aphasia Battery.
Exclusion Criteria
  • Severe apraxia of speech or dysarthria
  • Clinically significant depression
  • For MRI safety: implanted medical devices, metal in the body and claustrophobia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Distributed Intention Treatment (distributed-INT)Intention Treatment for AnomiaParticipants will receive 30 hours of Intention Treatment (INT) over 12 weeks.
Massed Intention Treatment (massed-INT)Intention Treatment for AnomiaParticipants will receive 30 hours of Intention Treatment (INT) over 3 weeks.
Primary Outcome Measures
NameTimeMethod
Number of correctly named picturesThrough study completion, an average of 6 months; Change from baseline to 3 weeks (post massed-INT) or 12 weeks (post distributed-INT), change at 3 months post-treatment, change at 6 months post-treatment

Change in the ability to correctly name 10 trained and 10 untrained pictures will be measured at 4 time points

Number of correctly generated category membersThrough study study completion, an average of 6 months; Change from baseline to 3 weeks (post m-INT) or 12 weeks (post d-INT), change at 3 months post-treatment, change at 6 months post-treatment

Change in the ability to correctly name 5 trained and 5 untrained category members will be measured at 4 time points

Western Aphasia BatteryBaseline

This standardized assessment will be administered at baseline to investigate language predictors of treatment outcome

Boston Naming TestBaseline

This standardized assessment will be administered at baseline to investigate language predictors of treatment outcome

Test of Everyday AttentionBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Brief Visuospatial Memory Test-RevisedBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Hopkins Verbal Learning Test-RevisedBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Digit Span BackwardsBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Delis-Kaplan Executive Function System (D-KEFS) SortingBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Structural MRI scanBaseline

Tissue health (from structural scan) will be obtained at baseline to investigate neural predictors of treatment outcome.

Functional MRI scanBaseline

Task-based activation location (from functional MRI scans) will be obtained at baseline to investigate neural predictors of treatment outcome.

Secondary Outcome Measures
NameTimeMethod
Delis-Kaplan Executive Function System (D-KEFS) TrailsBaseline

This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

Trial Locations

Locations (1)

Atlanta VA Medical and Rehab Center, Decatur, GA

🇺🇸

Decatur, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath